earnings
confidence high
sentiment positive
materiality 0.75
Carlsmed reports Q4 revenue ~$15.2M (+61% YoY); FY2025 ~$50.5M (+86% YoY)
CARLSMED, INC.
2025-FY EPS reported
-$2.12
revenue$50,511,000
- Preliminary Q4 2025 revenue of ~$15.2M, 61% increase over Q4 2024.
- Full-year 2025 revenue of ~$50.5M, 86% increase over 2024.
- Added 101 new surgeon users in 2025, a 61% increase in user base.
- Launched aprevo® cervical; early surgeon feedback encouraging.
- CEO cites transformational year; company focused on operational excellence for 2026.